Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Wilms Tumor Predisposition.

Dome JS, Huff V.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2003 Dec 19 [updated 2016 Oct 20].

2.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
3.

A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Abbaszadeh F, Barker KT, McConville C, Scott RH, Rahman N.

Fam Cancer. 2010 Sep;9(3):425-30. doi: 10.1007/s10689-009-9319-8.

PMID:
20054657
4.

Screening for Wilms tumor in high-risk individuals.

Clericuzio CL, Johnson C.

Hematol Oncol Clin North Am. 1995 Dec;9(6):1253-65. Review.

PMID:
8591963
5.

No excess of early onset cancer in family members of Wilms tumor patients.

Felgenhauer JL, Barce JM, Benson RL, Nan B, Olson JM, Breslow NE.

Cancer. 2001 Sep 15;92(6):1606-12.

PMID:
11745239
6.

Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.

Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA.

J Pediatr Surg. 2005 Feb;40(2):341-8.

PMID:
15750927
7.

Malformations, genetic abnormalities, and Wilms tumor.

Dumoucel S, Gauthier-Villars M, Stoppa-Lyonnet D, Parisot P, Brisse H, Philippe-Chomette P, Sarnacki S, Boccon-Gibod L, Rossignol S, Baumann C, Aerts I, Bourdeaut F, Doz F, Orbach D, Pacquement H, Michon J, Schleiermacher G.

Pediatr Blood Cancer. 2014 Jan;61(1):140-4. doi: 10.1002/pbc.24709. Epub 2013 Aug 23.

PMID:
23970395
8.

2q37 Microdeletion Syndrome.

Doherty ES, Lacbawan FL.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2007 May 3 [updated 2013 Jan 31].

9.

Identification of a novel CTR9 germline mutation in a family with Wilms tumor.

Martins AG, Pinto AT, Domingues R, Cavaco BM.

Eur J Med Genet. 2017 Dec 29. pii: S1769-7212(17)30590-6. doi: 10.1016/j.ejmg.2017.12.010. [Epub ahead of print]

PMID:
29292210
10.

Aniridia.

Hingorani M, Moore A.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2003 May 20 [updated 2013 Nov 14].

11.

Beckwith-Wiedemann Syndrome.

Shuman C, Beckwith JB, Weksberg R.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2000 Mar 3 [updated 2016 Aug 11].

12.

Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.

Jia W, Deng Z, Zhu J, Fu W, Zhu S, Zhang LY, Hu J, Wang F, Xia H, Liu GC, He J.

Cancer Invest. 2017 Nov 26;35(10):633-638. doi: 10.1080/07357907.2017.1405016.

PMID:
29243987
13.

Germline WT1 mutations in Wilms' tumor patients: preliminary results.

Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR, Pelletier J.

Med Pediatr Oncol. 1996 Nov;27(5):404-7.

PMID:
8827066
14.

Screening for Wilms' tumor in children with high-risk congenital syndromes: considerations for an intervention trial.

DeBaun MR, Brown M, Kessler L.

Med Pediatr Oncol. 1996 Nov;27(5):415-21. Review.

PMID:
8827068
15.

Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model.

McNeil DE, Brown M, Ching A, DeBaun MR.

Med Pediatr Oncol. 2001 Oct;37(4):349-56.

PMID:
11568898
16.

Familial Wilms tumor.

Ruteshouser EC, Huff V.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):29-34. Review.

PMID:
15264270
17.

Factor V Leiden Thrombophilia.

Kujovich JL.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
1999 May 14 [updated 2018 Jan 4].

18.

Current concepts in the biology and management of Wilms tumor.

Wiener JS, Coppes MJ, Ritchey ML.

J Urol. 1998 Apr;159(4):1316-25. Review.

PMID:
9507876
19.

B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence.

Routh JC, Ashley RA, Sebo TJ, Lohse CM, Husmann DA, Kramer SA, Kwon ED.

J Urol. 2008 May;179(5):1954-9; discussion 1959-60. doi: 10.1016/j.juro.2008.01.056. Epub 2008 Mar 20.

20.

Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.

Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G, et al.

Cancer Res. 1992 Nov 1;52(21):6117-20.

Supplemental Content

Support Center